Acino
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Thurgauerstrasse 36/38, Zurich, Zurich, ...Phone Number
+41 445552200Website
acino.swissRevenue
$632.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Acino
Founded in 1836, Acino is a pharmaceutical company headquartered in Zurich, Switzerland. Acino internationally markets, develops and manufactures innovative pharmaceuticals in novel drug delivery forms.Explore more
Acino Org Chart
KU
Head of Office Acino Ag Representative (Swiss...
VA
Head of HR, Operations, Meta
BM
Head of Supply Chain
AK
Africa Head of Supply Chain
MS
Distribution & Tenders, Head (Egypt)
AK
Subdivision QC Head
KL
Head of Supply Chain
NG
Quality Head
OK
Head of OTC BU
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acino your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Acino is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Acino launches new products
Funding: Get notified immidiatlly once Acino has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Acino had a recent Job posting/layoffs
Acino, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Acino
Earning: See what the market has to say on Acino recently announced quarterly report
Check if Acino has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Acino as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Acino is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acino is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acino.
Acino Tech Stack
A closer look at the technologies used by Acino
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Acino has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Event
Events, Compliance, Pharmaceuticals, Clinical Operations, Manufacturing Operations, Operations
Open Position
Hiring Plans
Hiring Plans
Acino News & Media
M8 Pharmaceuticals, an Acino company, Signs Exclusive Agreement with LG Chem for Novel Treatments for Type 2 Diabetes and Osteoarthritis in Latin America
MEXICO CITY, July 24, 2024 /PRNewswire/ -- M8 Pharmaceuticals, an Acino company ("M8"), today announces the signature of an exclusive licensing and distribution agreement with LG Chem Ltd., a global company headquartered in South Korea that specializes in life sciences as one of its core...Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024. Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by theM8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America
MEXICO CITY, May 7, 2024 /PRNewswire/ -- M8 Pharmaceuticals, an Acino company ('M8') announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) ('Supernus'), a biopharmaceutical company focused on the development and...M8 Pharmaceuticals, an Acino company, signs an exclusive agreement with SERB Pharmaceuticals to bring Voraxaze® (Glucarpidase) to Latin America
PARIS, March 20, 2024 /PRNewswire/ -- M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company, are collaborating to bring an important drug for cancer patients to Latin America. Under the agreement, M8 will register, market...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Acino
Sign Up For FreeTo access detailed company insights
Founded in 1836, Acino is a pharmaceutical company headquartered in Zurich, Switzerland. Acino internationally markets, develops and manufactures innovative pharmaceuticals in novel drug delivery forms.... Read More
